EFSCE
CORT icon

Enterprise Financial Services Corp (EFSC)’s Corcept Therapeutics CORT Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,777
Closed -$5K – 1282
2014
Q4 		$5K Buy
+1,777
New +$5.42K ﹤0.01% 790
2014
Q3 		– Sell
-2,276
Closed -$6K – 1263
2014
Q2 		$6K Buy
2,276
+442
+24% +$1.3K ﹤0.01% 750
2014
Q1 		$8K Buy
+1,834
New +$6.41K ﹤0.01% 678

Other funds holding CORT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s CORT Position: Q1 2015 in Review

Enterprise Financial Services Corp (EFSC) sold out of Corcept Therapeutics (CORT) in Q1 2015, closing a stake of 1,777 shares — an estimated $5K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in CORT in Q1 2014 and held it in 3 quarters. The position peaked at $8K in Q1 2014. 64 funds tracked by Wall St. Rank hold CORT as of Q1 2015.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Corcept Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 1,777 Corcept Therapeutics shares in Q1 2015, an estimated $5K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Corcept Therapeutics in Q1 2014 and held it in 3 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Corcept Therapeutics position peaked at $8K in Q1 2014.
  • 64 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2015.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q1 2015, filed 29 Apr 2015.